Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Elekta AB ( ($SE:EKTA.B) ) just unveiled an announcement.
Elekta will host a Capital Markets Day on June 17, 2026, in Stockholm, inviting investors, analysts and other stakeholders to attend in person or online. The company plans to outline its strategy and financial targets, with CEO Jakob Just-Bomholt, CFO Klara Eiritz and other leaders presenting key actions, priorities and assumptions underpinning its execution, and a recording will later be made available on Elekta’s website.
The event is designed to deepen market understanding of Elekta’s long-term direction and performance ambitions in precision radiation therapy. By detailing strategic priorities and financial goals, the company aims to strengthen engagement with the investment community and provide greater transparency for stakeholders tracking its positioning in the global cancer care market.
The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK45.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta AB is a Stockholm-headquartered medical technology company specializing in precision radiation therapy systems and software for cancer care. With around 4,500 employees and offices in more than 40 countries, it focuses on sustainable, outcome-driven and cost-efficient oncology solutions and is listed on Nasdaq Stockholm.
Average Trading Volume: 1,201,623
Technical Sentiment Signal: Hold
Current Market Cap: SEK21.78B
For an in-depth examination of EKTA.B stock, go to TipRanks’ Overview page.